Article

Histological variant-specific significance of lymph node metastasis for the prognosis of metastatic urothelial carcinoma treated with pembrolizumab: A retrospective multicentric study (YUSHIMA study-04)

2025-09-30

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Histological variants (HV) are associated with aggressiveness in urothelial carcinoma (UC). Although immune checkpoint inhibitor (ICI) therapy has improved the prognosis of patients with metastatic UC with HV, the factors determining the prognosis of these patients following ICI therapy remains unclear. <bold>Methods</bold> The present, retrospective, multic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 54c721d4-c3e5-525b-b215-6c1111f844ee
DOI: 10.21203/rs.3.rs-7630865/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Histological variant-specific significance of lymph node metastasis for the prognosis of metastatic urothelial carcinoma treated with pembrolizumab: A retrospective multicentric study (YUSHIMA study-04)DOI 10.21203/rs.3.rs-7630865/v1Read

Real-World Outcomes of Second-Line Pembrolizumab in Urothelial Carcinoma: A Multicenter Analysis from the Campania Oncological Network (ROC)Semantic proximity Read

Subtype-specific benefit of adjuvant chemotherapy in non-metastatic muscle-invasive bladder cancer with histologic variants: a four-endpoint, subtype-stratified analysisSemantic proximity Read

A multicenter review of histopathology of variants in the context of upper urinary tract urothelial carcinoma and their impact on clinical outcomesSemantic proximity Read

Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial CarcinomaSemantic proximity Read

Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study.Semantic proximity Read

Molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinomaSemantic proximity Read

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.Semantic proximity Read

Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer.Semantic proximity Read

Novel molecular biomarkers to guide treatment-decision making in metastatic urothelial cancer - A patient cohort analysisSemantic proximity Read

Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.Semantic proximity Read

The genomic and transcriptomic landscape of metastastic urothelial cancer.Semantic proximity Read

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohortSemantic proximity Read